BiomeBank

BiomeBank is a clinical-stage biotechnology company developing a pipeline of microbiome therapies and live biotherapeutic products for the treatment of diseases. BiomeBank's mission is to treat and prevent disease by replenishing the gut microbiome ecosystem. The company’s BiomeBoost is a pharmaceutical product containing a broad spectrum of microbes, used for treating recurrent Clostridioides difficile infections.